Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trialsCandidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosisSelenium supplementation for the primary prevention of cardiovascular diseaseNiacin for primary and secondary prevention of cardiovascular eventsSelenium supplementation for the primary prevention of cardiovascular diseaseHypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesEffect of supplemental vitamin E for the prevention and treatment of cardiovascular diseaseEvaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineVitamins C and E: beneficial effects from a mechanistic perspectiveOpening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular riskEzetimibe therapy: mechanism of action and clinical updateEfficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trialsVitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trialEffects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot studyThe Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice.The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]Microencapsulated Genetically EngineeredLactobacillus plantarum80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering CholesterolVitamin C and Heart Health: A Review Based on Findings from Epidemiologic StudiesHigh density lipoprotein and metabolic disease: Potential benefits of restoring its functional propertiesNiacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part I: Alternative Niacin Regimens.Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future researchNiacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?Antioxidants, inflammation and cardiovascular diseaseOrigin and therapy for hypertriglyceridaemia in type 2 diabetesTargeting NADPH oxidases in vascular pharmacologyEffects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trialsNiacin, an old drug with a new twistAntioxidants and coronary artery disease: from pathophysiology to preventive therapyRegression of atherosclerosis: insights from animal and clinical studiesComplexity of vitamin E metabolismPost-transplant dyslipidemia: Mechanisms, diagnosis and managementNiacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?Treatment of metabolic syndromeDiagnosis and management of the metabolic syndrome in obesityMediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trialPreventive therapy in patients with insignificantly narrowed coronary arteries: evaluation of physician attitude and practiceAdvances in diabetes for the millennium: vitamins and oxidant stress in diabetes and its complicationsOptimal lipid modification: the rationale for combination therapy
P2860
Q21090716-A694A1A6-C136-41EF-A275-59AE8F771128Q21133673-AE7D7E21-7876-43C4-8E16-9B1377FD3A8EQ21261519-D6EE6436-396D-4E7F-8AE0-5C518D9650BCQ24201670-8A9A45CC-FB98-4751-85BE-D483C05B03AFQ24203613-58B45580-DE16-4452-AC8C-495907F05213Q24203785-DCAFA94E-C445-4219-8FBA-AD0844937518Q24242787-00F7403C-ABD7-4A63-8F9B-99B6476985E7Q24242944-469664F1-D483-4AEE-9804-5AD431A0F6F6Q24550510-E32338EC-C4F5-4754-B141-8A3A6AAFBFB4Q24608464-E8487073-AEBB-4B41-8DD0-33848D776FF0Q24617202-4D99466D-DFFA-454E-AFDD-92BBCD4D8A08Q24626884-E73E60DC-2926-4980-BE9C-AEC76B522B65Q24630302-7B025D73-CDD8-473B-A771-B7066085E020Q24632223-63043CCB-E4ED-4E37-92EA-BCFE887D3EC4Q24654699-19697878-1608-406F-8702-C7A5933C80CAQ24793945-34987B07-FF37-4409-AFFB-F2A010ECD0B6Q24794251-F6DDB259-C615-4742-959F-73EAF5151CEEQ24797790-9DCA778B-B2A2-4EE8-8535-093AC7B6BD09Q24809565-4AD7B12D-D45D-4A04-B2CA-554A33615833Q26741195-243B9029-BADC-45CB-9F28-CA9D64625100Q26750603-BC5C9830-1ADA-4A60-99B1-EF9142989F26Q26766157-8F6CA149-3118-4511-982D-629AB25B40A3Q26782844-8F7013D7-0C07-4056-A2C8-9261949F267FQ26799534-038A1FB5-6D52-4B6D-8323-84F8838A68AEQ26823009-920CF27C-8492-4BD8-8168-74D38811D9DFQ26824004-9105A3D5-18FC-4B0F-87D6-F99E616C0913Q26863500-EDFF9CEB-1207-4F6F-83AF-7CEBBF5F794EQ26991955-E0384486-275A-4541-A08F-D46DEC0ABFD5Q27002774-6EE12399-7072-407A-89C1-C3BAC6C46FA9Q27025669-9758457C-E4FC-4DC3-9547-785E7252109BQ27028112-7B6417E9-BA44-49D3-892B-F5E8B4B23792Q28068513-D94E49C1-2A6C-4AFF-A28B-C09DF4C222BFQ28076119-09C43220-0596-4B93-A671-0CE604F79449Q28086787-6075A70B-3B44-4E11-9994-BB46B92FA657Q28168652-601C21F8-D046-400A-B3F9-C8FDA027E996Q28192856-CCA0B0F4-EAFB-471F-8869-D4EA9A2B182FQ28195696-4C8FC47F-082E-410F-9863-36F902312989Q28198765-7615207D-5F36-4731-87A1-41C12FAA7E73Q28213075-949B5CA8-9F18-4384-B979-394814D5A06DQ28219266-011B9943-E4E7-4FC4-ACC4-D462FFFC73C2
P2860
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Simvastatin and niacin, antiox ...... revention of coronary disease.
@en
Simvastatin and niacin, antiox ...... revention of coronary disease.
@nl
type
label
Simvastatin and niacin, antiox ...... revention of coronary disease.
@en
Simvastatin and niacin, antiox ...... revention of coronary disease.
@nl
prefLabel
Simvastatin and niacin, antiox ...... revention of coronary disease.
@en
Simvastatin and niacin, antiox ...... revention of coronary disease.
@nl
P2093
P356
P1476
Simvastatin and niacin, antiox ...... revention of coronary disease.
@en
P2093
Alaupovic P
Frohlich J
P304
P356
10.1056/NEJMOA011090
P407
P577
2001-11-01T00:00:00Z